Grown Rogue International (GRUSF) Other financing activities (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly Other financing activities of $21839.0 for Q1 2026, up 36.17% year-over-year from $16038.0 in Q1 2025, and up 100.0% quarter-over-quarter from -$405.9 billion in Q4 2025.
Grown Rogue International (GRUSF) Other financing activities (2009 - 2026) Analysis & Trends
Grown Rogue International's Other financing activities history runs 12 years deep, the most recent figure standing at $21839.0 for Q1 2026.
- In Q1 2026, Other financing activities rose 36.17% year-over-year to $21839.0; the TTM figure through Mar 2026 stood at $412745.0 (down 90.74% YoY), while the FY2025 annual figure was $406944.0, down 91.17% from the prior year.
- Other financing activities for Q1 2026 stood at $21839.0, up from -$405.9 billion in the prior quarter.
- The five-year high for Other financing activities was $405.9 billion in Q3 2025, with the low at -$405.9 billion in Q4 2025.
- The 4-year median for Other financing activities is $97804.0 (2024), against an average of $633836.0.
- Peak annual rise in Other financing activities reached 1321.43% in 2025, while the deepest fall reached 90.46% in 2025.
- Grown Rogue International's Other financing activities stood at $1.3 million in 2022, then tumbled by 27688822.34% to -$360.0 billion in 2024, then fell by 12.76% to -$405.9 billion in 2025, then surged by 100.0% to $21839.0 in 2026.
- Business Quant data shows GRUSF's Other financing activities at $21839.0 in Q1 2026, -$405.9 billion in Q4 2025, and $405.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Grown Rogue International | 109.32 Mn | 97.78 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21,839.00 |
| Mar 31, 2026 | 21,839.00 |
| Dec 31, 2025 | -405.87 Bn |
| Dec 31, 2025 | -405.87 Bn |
| Sep 30, 2025 | 405.87 Bn |
| Sep 30, 2025 | 405.87 Bn |
| Jun 30, 2025 | 389,828.00 |
| Jun 30, 2025 | 389,828.00 |
| Mar 31, 2025 | 16,038.00 |
| Mar 31, 2025 | 16,038.00 |
| Dec 31, 2024 | -359.95 Bn |
| Dec 31, 2024 | -359.95 Bn |
| Sep 30, 2024 | 359.96 Bn |
| Sep 30, 2024 | 359.96 Bn |
| Jun 30, 2024 | 27,425.00 |
| Jun 30, 2024 | 27,425.00 |
| Mar 31, 2024 | 168,183.00 |
| Mar 31, 2024 | 168,183.00 |
| Jan 31, 2022 | 1.30 Mn |
| Jan 31, 2022 | 1.30 Mn |